CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials Major infections after bypass surgery and stenting: an overlooked but fatal complication Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD

Original Research2021 Jan 22.

JOURNAL:Circulation. Article Link

Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study

D Pellegrini, R Kawakami, G Guagliumi et al. Keywords: COVID-19; SARS-CoV-2; cardiovascular disease; autopsy results.

Full Text PDF